Ticker Symbol: RGC

Regencell Bioscience Holdings Ltd

$26.45 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001829667

Company Profile

Regencell Bioscience Holdings Limited is an early-stage bioscience company that focuses on research, development and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, specifically ADHD and ASD. The Company started in Hong Kong in 2014 and completed its first research study using personalized TCM formula in Hong Kong. The Company aims to launch three liquid-based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients in Hong Kong first and subsequently to other markets.

Sector: Manufacturing

Industry: Medicinal and Botanical Manufacturing

Standard Industrial Classification Code (SIC code): 2833

Address: N/A

Website: www.regencellbioscience.com

CEO: N/A

Tags: N/A

Pricing

Last Updated: December 31, 1969 07:00 PM EST

Previous Close: -

Change: -$0.50 ( -3.03%)

Days Range: $16.00 - $16.50

Beta: -

52wk. High: $33.82

52wk. Low: $10.70

Ytd. Change -45.66%

50 Day Moving Average: $15.35

200 Day Moving Average: $19.73

Shares Outstanding: 12642105

Valuation

Market Cap: 20.2B

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A